Birdwatch Note
2024-11-04 16:23:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
レプリコンワクチンは3か月の治験期間中に死因を問わず約８千人中5人のワクチン接種群が死亡し(うちコロナ死1)プラセボ群は訳８千人中16人が死亡(うちコロナ死9)という結果がでています RNAの無限増殖やシェディング（伝搬）と言った事は、この規模の数でわかる話としては全く起きていません https://prtimes.jp/main/html/rd/p/000000002.000118477.html https://www.nature.com/articles/s41467-024-47905-1/tables/2 https://www.nature.com/articles/s41467-024-47905-1 日本語資料は下記pdfの28P目,資料の24P目 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf なお当該治験は17.4%程の高齢者が参加しています https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間8000人中56人程がなくなる国です https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN 診療を要する有害事象を経験した方の数も接種群12.1%,プラセボ群14.6%でした。 https://www.nature.com/articles/s41467-024-47905-1
Written by 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1853444870524055633
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1853473048911065093
- noteId - 1853473048911065093
- participantId -
- noteAuthorParticipantId - 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442 Participant Details
- createdAtMillis - 1730737385382
- tweetId - 1853444870524055633
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- レプリコンワクチンは3か月の治験期間中に死因を問わず約８千人中5人のワクチン接種群が死亡し(うちコロナ死1)プラセボ群は訳８千人中16人が死亡(うちコロナ死9)という結果がでています RNAの無限増殖やシェディング（伝搬）と言った事は、この規模の数でわかる話としては全く起きていません https://prtimes.jp/main/html/rd/p/000000002.000118477.html https://www.nature.com/articles/s41467-024-47905-1/tables/2 https://www.nature.com/articles/s41467-024-47905-1 日本語資料は下記pdfの28P目,資料の24P目 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf なお当該治験は17.4%程の高齢者が参加しています https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間8000人中56人程がなくなる国です https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN 診療を要する有害事象を経験した方の数も接種群12.1%,プラセボ群14.6%でした。 https://www.nature.com/articles/s41467-024-47905-1
Note Ratings
| rated at | rated by | |
| 2024-11-04 17:49:56 -0600 | Rating Details | |
| 2024-11-04 17:44:44 -0600 | Rating Details | |
| 2024-11-04 17:02:00 -0600 | Rating Details | |
| 2024-11-04 16:08:05 -0600 | Rating Details | |
| 2024-11-04 16:06:04 -0600 | Rating Details | |
| 2024-11-04 15:19:53 -0600 | Rating Details | |
| 2024-11-04 14:20:23 -0600 | Rating Details | |
| 2024-11-04 11:09:17 -0600 | Rating Details | |
| 2024-11-05 17:13:19 -0600 | Rating Details | |
| 2024-11-05 07:40:02 -0600 | Rating Details | |
| 2024-11-05 07:36:58 -0600 | Rating Details | |
| 2024-11-05 06:22:02 -0600 | Rating Details | |
| 2024-11-05 05:53:45 -0600 | Rating Details | |
| 2024-11-05 05:13:13 -0600 | Rating Details | |
| 2024-11-05 04:58:44 -0600 | Rating Details | |
| 2024-11-05 04:41:21 -0600 | Rating Details | |
| 2024-11-05 02:59:33 -0600 | Rating Details | |
| 2024-11-05 01:57:19 -0600 | Rating Details | |
| 2024-11-05 01:25:25 -0600 | Rating Details | |
| 2024-11-05 00:42:16 -0600 | Rating Details | |
| 2024-11-04 23:57:44 -0600 | Rating Details | |
| 2024-11-04 23:30:15 -0600 | Rating Details | |
| 2024-11-04 22:11:36 -0600 | Rating Details | |
| 2024-11-04 21:23:29 -0600 | Rating Details | |
| 2024-11-04 21:17:43 -0600 | Rating Details | |
| 2024-11-04 21:15:57 -0600 | Rating Details | |
| 2024-11-04 20:55:05 -0600 | Rating Details | |
| 2024-11-04 20:48:07 -0600 | Rating Details | |
| 2024-11-04 20:36:05 -0600 | Rating Details | |
| 2024-11-04 20:31:18 -0600 | Rating Details | |
| 2024-11-04 20:04:50 -0600 | Rating Details | |
| 2024-11-04 19:38:12 -0600 | Rating Details | |
| 2024-11-04 19:35:38 -0600 | Rating Details | |
| 2024-11-04 19:32:08 -0600 | Rating Details | |
| 2024-11-04 16:40:46 -0600 | Rating Details | |
| 2024-11-04 16:36:22 -0600 | Rating Details | |
| 2024-11-04 16:19:37 -0600 | Rating Details | |
| 2024-11-04 16:18:58 -0600 | Rating Details | |
| 2024-11-04 15:18:10 -0600 | Rating Details | |
| 2024-11-04 12:56:55 -0600 | Rating Details | |
| 2024-11-04 11:00:14 -0600 | Rating Details | |
| 2024-11-04 10:24:57 -0600 | Rating Details | |
| 2024-11-05 17:34:47 -0600 | Rating Details | |
| 2024-11-05 08:44:22 -0600 | Rating Details | |
| 2024-11-05 06:58:33 -0600 | Rating Details | |
| 2024-11-04 20:58:45 -0600 | Rating Details | |
| 2024-11-04 19:52:31 -0600 | Rating Details | |
| 2024-11-04 18:53:19 -0600 | Rating Details | |
| 2024-11-04 17:35:32 -0600 | Rating Details | |
| 2024-11-04 15:07:48 -0600 | Rating Details | |
| 2024-11-04 11:37:40 -0600 | Rating Details | |
| 2024-11-04 10:37:45 -0600 | Rating Details | |
| 2024-11-05 14:34:07 -0600 | Rating Details | |
| 2024-11-05 06:31:21 -0600 | Rating Details | |
| 2024-11-05 04:18:30 -0600 | Rating Details | |
| 2024-11-05 02:11:03 -0600 | Rating Details | |
| 2024-11-04 23:04:16 -0600 | Rating Details | |
| 2024-11-04 22:41:27 -0600 | Rating Details | |
| 2024-11-04 20:10:02 -0600 | Rating Details | |
| 2024-11-04 19:02:59 -0600 | Rating Details | |
| 2024-11-04 17:33:38 -0600 | Rating Details | |
| 2024-11-04 17:03:28 -0600 | Rating Details | |
| 2024-11-04 16:54:07 -0600 | Rating Details | |
| 2024-11-04 16:37:32 -0600 | Rating Details | |
| 2024-11-04 16:33:33 -0600 | Rating Details | |
| 2024-11-04 16:25:22 -0600 | Rating Details | |
| 2024-11-04 10:44:58 -0600 | Rating Details | |
| 2024-11-19 10:38:20 -0600 | Rating Details |